Currently, there are 20.93M common shares owned by the public and among those 20.33M shares have been available to trade.
Insiders at the company have transacted a total of 4 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 4 of these insider trades were purchases, accounting for 17,850 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 0.7890, up 16.76%. The company’s stock has a 5-day price change of 68.12% and 33.29% over the past three months. MARK shares are trading 20.56% year to date (YTD), with the 12-month market performance down to -52.24% lower. It has a 12-month low price of $0.32 and touched a high of $2.79 over the same period. MARK has an average intraday trading volume of 6.27 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 18.68%, 19.60%, and -20.60% respectively.
Institutional ownership of Remark Holdings Inc (NASDAQ: MARK) shares accounts for 16.23% of the company’s 20.93M shares outstanding.
It has a market capitalization of $12.50M and a beta (3y monthly) value of 2.69. The earnings-per-share (ttm) stands at -$2.20. Price movements for the stock have been influenced by the stock’s volatility, which stands at 96.98% over the week and 38.27% over the month.
The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0.
Looking at the support for the MARK, a number of firms have released research notes about the stock. ROTH Capital stated their Buy rating for the stock in a research note on January 31, 2018, with the firm’s price target at $10.25-$20.50.
